Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Johnson & Johnson plans to eliminate approximately 900 jobs from its Ortho-McNeil-Janssen pharmaceutical unit, reported Reuters.
Subscribe to our email newsletter
According to the news source, most of the job cuts are likely to involve sales personnel. The reduction also involves attrition and hiring freezes.
Loss of patent protection, lack of new medicines and increase in generic competition are reported to be some of the reasons behind the recent job cuts implemented by the global pharmaceutical companies.